People
PPLI
40.59
-0.70
-1.70%
People
US · PPLI
#2469 by market cap
Listed 1970
40.59
-0.70
-1.70%
Live - 5344 symbols - heartbeat 366s ago
· 2026-10-07 19:54
After-hours
40.59
0.00%
- Market cap
- 3.02B
- P/E (TTM)i
- 9.18
- P/Bi
- 0.59
- EPSi
- -1.30
- Div yieldi
- 0.00%
- 52W posi
- 59%
Reader sentiment
Are you bullish or bearish on PPLI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.20, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -8.73% YoY
Margins
- Gross margin
- 66.16%
- Operating margin
- 4.60%
- Net margin
- -4.35%
Key ratios & quality
- Enterprise valuei
- 3.49B
- Altman Z-Scorei
- 1.20
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.53B | 2.51B | 2.76B | 3.70B | 5.24B | 2.92B | 2.62B | 2.39B |
| Gross profit | 2.03B | 1.96B | 2.02B | 2.40B | 3.30B | 1.70B | 1.62B | 1.58B |
| Selling & admin expenses | 1.67B | 1.69B | 1.91B | 2.16B | 2.91B | 1.32B | 1.24B | 1.15B |
| Research & development | 177.30M | 132.64M | 185.34M | 230.81M | 318.03M | 237.95M | 228.33M | 196.02M |
| Operating profit | 35.84M | 9.05M | -272.52M | -137.07M | -362.02M | -228.78M | -28.68M | 110.04M |
| Pretax profit | 305.57M | 34.32M | 244.16M | 729.81M | -1.53B | 393.03M | -715.04M | -81.91M |
| Tax | 13.20M | -47.35M | -45.71M | 138.99M | -331.09M | 98.16M | -141.87M | 34.85M |
| Net profit | 292.37M | 32.18M | 268.59M | 588.99M | -1.19B | 258.32M | -533.33M | -101.47M |
| Basic EPS | 3 | 0 | 3 | 7 | -14 | 3 | -6 | -1 |
| Diluted EPS | 2.90 | 0.27 | 2.97 | 6.31 | -13.55 | 2.97 | -6.49 | -1.30 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 481.69M | 443.25M | 589.79M | 645.98M | 422.89M | 436.74M |
| Gross profit | 294.37M | 282.46M | 382.34M | 450.93M | 263.12M | 280.20M |
| Selling & admin expenses | 200.85M | 226.11M | 320.74M | 279.10M | 237.14M | 234.25M |
| Research & development | 35.74M | 34.16M | 49.49M | 46.50M | 39.70M | 33.69M |
| Operating profit | 24.12M | -7.49M | -20.40M | 94.08M | -40.07M | -14.29M |
| Pretax profit | -320.82M | 265.57M | -49.00M | 2.53M | -17.83M | 692.08M |
| Tax | -62.48M | 74.36M | -27.26M | 78.30M | -15.58M | 177.35M |
| Net profit | -214.57M | 210.63M | -21.74M | -75.80M | -70.67M | 507.84M |
| Basic EPS | -3 | 3 | 0 | -1 | -1 | 7 |
| Diluted EPS | -2.64 | 2.57 | -0.27 | -0.99 | -0.94 | 6.68 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.76B | 1.23B | 4.12B | 3.08B | 2.56B | 2.24B | 2.49B | 1.54B |
| Cash & ST investments | 2.26B | 839.80M | 3.59B | 2.14B | 1.66B | 1.45B | 1.38B | 960.21M |
| Inventory | -- | -- | 317.00K | -- | -- | -- | -- | -- |
| Total assets | 6.87B | 4.10B | 9.16B | 12.30B | 10.39B | 10.37B | 9.69B | 7.13B |
| Total current liabilities | 883.56M | 585.32M | 750.90M | 1.38B | 1.08B | 950.49M | 886.19M | 560.87M |
| Short-term debt | 13.75M | 13.75M | -- | 30.00M | 30.00M | 30.00M | 35.00M | 24.50M |
| Long-term debt | 2.25B | 231.95M | 712.28M | 2.05B | 2.02B | 1.99B | 1.44B | 1.40B |
| Total liabilities | 3,257,097,000.00 | 1,048,444,000.00 | 1,778,789,000.00 | 4,534,892,000.00 | 3,793,866,000.00 | 3,582,796,000.00 | 3,384,256,000.00 | 2,341,706,000.00 |
| Total equity | 3.62B | 3.05B | 7.38B | 7.77B | 6.60B | 6.79B | 6.30B | 4.79B |
| Retained earnings | 1.26B | 0 | 694.04M | 905.15M | -265.02M | 923.00K | -538.97M | -643.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.69B | 1.60B | 1.52B | 1.54B | 1.55B | 1.55B |
| Cash & ST investments | 1.16B | 1.09B | 1.01B | 960.21M | 1.11B | 1.11B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 7.19B | 7.36B | 7.19B | 7.13B | 6.82B | 7.52B |
| Total current liabilities | 627.40M | 558.65M | 591.67M | 560.87M | 419.78M | 420.40M |
| Short-term debt | 42.33M | 21.00M | 22.75M | 24.50M | 24.50M | 24.50M |
| Long-term debt | 1.42B | 1.41B | 1.41B | 1.40B | 1.40B | 1.39B |
| Total liabilities | 2,424,393,000.00 | 2,397,613,000.00 | 2,343,959,000.00 | 2,341,706,000.00 | 2,225,532,000.00 | 2,389,820,000.00 |
| Total equity | 4.76B | 4.96B | 4.84B | 4.79B | 4.59B | 5.13B |
| Retained earnings | -755.78M | -544.33M | -566.21M | -643.00M | -714.88M | -208.03M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 369.44M | 251.80M | 154.58M | 136.95M | -82.79M | 189.53M | 354.52M | 61.28M |
| Depreciation & amortization | 149.47M | 129.69M | 195.66M | 149.85M | 438.70M | 368.95M | 182.74M | 130.63M |
| Free cash flow | 314.76M | 156.70M | 93.86M | 46.74M | -222.54M | 95.94M | 339.50M | 42.08M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -56.91M | 1.34B | -35.40M | -93.47M | -165.62M | 0 | 84.96M |
| Ending cash balance | 886.84M | 840.73M | 3.48B | 2.12B | 1.43B | 1.31B | 1.81B | 986.83M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.69M | 105.10M | -77.71M | 36.58M | 15.39M | -126.55M |
| Depreciation & amortization | 33.66M | 29.69M | 36.03M | 31.25M | 26.35M | 26.55M |
| Free cash flow | -6.83M | 101.08M | -83.54M | 31.37M | 7.43M | -137.74M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -179.39M | 379.39M | -500.00M | 384.96M | -123.57M | -9.68M |
| Ending cash balance | 1.17B | 1.10B | 1.02B | 986.83M | 1.12B | 1.12B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.68 | 14.94 | 5.66 | 8.39 | -17.86 | 4.28 | -9.26 | -2.02 |
| ROA %i | 3.59 | 5.67 | 3.09 | 5.39 | -10.31 | 2.47 | -5.42 | -1.25 |
| ROIC %i | 4.91 | 9.73 | 4.14 | 7.28 | -12.81 | 3.95 | -6.22 | -0.72 |
| 5-year avg ROE %i | -- | -- | -- | -- | 1.19 | 0.31 | -1.71 | -3.30 |
| EBIT margin %i | 12.58 | 13.62 | 7.41 | 20.65 | -27.05 | 12.02 | -14.09 | 1.59 |
| FCF / sales %i | 12.43 | 16.84 | 3.05 | 1.26 | -- | 1.10 | 7.59 | 1.76 |
| Current ratioi | 3.13 | 2.10 | 5.49 | 2.23 | 2.37 | 2.36 | 2.80 | 2.75 |
| Quick ratioi | 2.88 | 1.84 | 5.13 | 2.05 | 2.10 | 2.09 | 2.10 | 2.51 |
| Debt / assetsi | 32.86 | 6.00 | 7.77 | 16.88 | 19.72 | 19.51 | 15.17 | 20.00 |
| LT debt / equityi | 78.98 | 9.15 | 10.80 | 28.52 | 34.05 | 32.79 | 25.73 | 29.60 |
| Interest coveragei | 24.40 | 4.22 | 13.96 | 22.30 | -12.85 | 3.33 | -3.44 | 0.32 |
| Revenue CAGR (3Y) %i | -- | -- | -5.80 | 13.46 | 27.77 | 1.83 | -10.84 | -22.97 |
| Net income CAGR (3Y) %i | -- | -- | -4.01 | 34.28 | -- | -0.47 | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -34.96 | -47.04 | -- | 0.74 | 93.66 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -14.75 | -8.21 | -4.29 | -2.02 | 0.88 | 6.73 |
| ROA %i | -9.12 | -5.10 | -2.66 | -1.25 | 0.58 | 4.52 |
| ROIC %i | -10.50 | -5.50 | -2.59 | -0.72 | 1.46 | 5.96 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -25.26 | -13.13 | -4.93 | 1.59 | 14.51 | 32.13 |
| FCF / sales %i | 6.58 | 3.55 | 1.78 | 1.76 | 2.41 | -- |
| Current ratioi | 2.70 | 2.87 | 2.56 | 2.75 | 3.69 | 3.69 |
| Quick ratioi | 2.47 | 2.63 | 2.37 | 2.51 | 3.43 | 3.43 |
| Debt / assetsi | 20.34 | 19.47 | 19.89 | 20.00 | 20.82 | 18.81 |
| LT debt / equityi | 30.12 | 28.76 | 29.37 | 29.60 | 30.68 | 27.35 |
| Interest coveragei | -6.34 | -3.20 | -1.24 | 0.32 | 2.88 | 7.20 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- People Inc. is the largest reported line at 96.76% of revenue, across 3 reported segments.
- The next-largest line, Emerging & Other, is a distant second at 4.59% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
People Inc.96.76%
Emerging & Other4.59%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.